A Phase 1 trial will evaluate the use of gene therapy in delivering brain-derived neurotrophic factor (BDNF) to the brains of people with Alzheimer’s disease or mild cognitive impairment (MCI), which often precedes dementia. Researchers at the University of California San Diego (UCSD) School of Medicine are preparing to open a three-year trial in 12 people diagnosed with either with Alzheimer’s or MCI, according to a university press release. The release did not specify if eligible…
You must be logged in to read/download the full post.
The post Phase 1 Trial to Test BDNF Gene Therapy in Alzheimer’s Patients appeared first on BioNewsFeeds.